Devicor Medical Products, Inc.
300 E-Business Way, Fifth Floor
Cincinnati, OH 45241 USA
Tel: 1-877-926-2666
Fax: 1-888-260-6362
e-mail: customerservice@mammotome.com
URL: www.mammotome.com
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
“neo2000®” work mark and the “neoprobe” logo are registered trademarks of Devicor Medical Products,
Inc.
"Bluetooth®" word mark and logos are owned by Bluetooth SIG, Inc. and any use by Devicor or its
representatives is under license.
This document is sole property of Devicor Medical Products, Inc.. Any duplication, reproduction, or
transmission of document or any of its content to unauthorized parties without prior written permission of
Devicor Medical Products, Inc. is prohibited.
9. SYSTEM SPECIFICATIONS .................................................................................................................................................................. 30
Electronic medical device for detecting and quantifying gamma radiation
Indications
Used externally and intraoperatively to detect radioactive emissions from body tissues
or organs where radiopharmaceuticals are administered. There are no known
contraindications in the application or use of the device.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
1. INTRODUCTION
The neoprobe
TM
Gamma Detection System console, with BLUETOOTH® wireless technology, detects presence of
gamma rays emitted from radioactive isotopes in body organs or tissue. System provides an increasing or decreasing
sound and visual indicator (Count Bar) that vary in pitch as level of gamma radioactivity increases or decreases.
Detecting gamma radiation with a hand-held probe is based on inverse square law of physics which allows detection
of radiation emitted from a small source. Placing probe close to radioactive site increases number of counts detected
and localization occurs. Excision of lesion is then performed using standard surgical technique.
Gamma detection protocols that control use of large, highly collimated scintillation detectors may require
modifications when used in conjunction with hand-held gamma probe.
NOTE: User is responsible to determine suitability of product for use in any surgical procedure. Contact Devicor
regarding questions for intended use of product.
CAUTION: United States Federal law restricts this device to sale by or on order of a physician.
CAUTION: Read Warnings, Cautions and Notes section before operating product.
CAUTION: Clean and sterilize probe and collimator before use; use sterile surgical probe cover if not
sterilized.
NOTE: Save packing material to return product for service.
NOTE: Accessories packaged separately from control unit (console) during shipment. Verify you have received all
items ordered.
Visual Indicators and Controls
Visual information and data viewed on LED screen. Visual information displayed in Liquid Crystal fonts and
translated in this manual; example - “No Linc” is displayed as “no linc” “on LED screen.
Connect Model 2009 power cord to console and into AC power source. DO NOT USE EXTENSION
CORD. Maintain proper clearance for access to AC Power Inlet Connector for disconnection from
mains power.
2
Press and release Standby/On button
Console powers on; displays software version; and operates in Dynamic Pitch Mode
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
NOTE: [Numbers] are repeated in following text to identify indicator or control.
* Functionality of button [11] same as button on probe with BLUETOOTH® wireless technology. See wireless probe
operation manual.
2. EQUIPMENT ASSEMBLY
NOTE: Console is equipped with BLUETOOTH® wireless technology and is compatible with both BLUETOOTH®
wireless technology enabled probes and cabled probes. User can select either probe type to use with console. A
wireless probe cannot be operated at the same time a cabled probe is in use.
When base Binary or Dynamic Pitch Mode (not performing a 10-second count, etc), user can press and hold
Background Count Button. After five seconds, a Start Beep sounds and wireless probe will turn off. Note: It takes an
additional five seconds before system displays “no Linc”.
If Radionuclide Button is pressed and held for more than one second, user will hear a “start beep” and all radionuclide
indicators will go out. This signifies an Open Window setting. Exit Open Window by pressing and releasing
Radionuclide button (last radionuclide selected is restored).
When in base Binary or Dynamic Pitch Mode (not performing a 10-second count, etc) and a wireless probe battery is
low, Ratio Indicator will show “Lo” and Background Count will show “batt” for two seconds. A low battery chime
is sounded and No Probe Connected Icon turns on for two seconds, then turns off. Previous values are
restored. Message is seen every 20 seconds.
Using aseptic technique (without sterile surgical drape) connect probe to Model 2024 or Model 2060 probe cable;
align red dot on probe to red dot on cable connector; gently insert cable into Probe Input Connector; if using a sterile
surgical drape - place probe in drape now
3
Align arrow on cable connector and groove in Probe Input Connector [5] on console; gently insert cable connector
neoprobeTM system is now ready for use
To….
Perform following…..
And this occurs……
Turn system on
See Equipment Assembly
above
“Dynamic Pitch” indicator [4] is lit
Dynamic Pitch Range automatically set to 0-100
count range, and default background count is 2 cps
Radionuclide automatically set to Technetium 99m
(
99m
TC), and indicator [3] is lit
Select Dynamic Pitch
count range different
from 0-100
Press and release
Dynamic Pitch Count
Range selection buttons
[18].
Indicator for desired Count Range is lit [18];
Background Count Readout [ 8] changes to default
for selected Count Range
Select a radionuclide
different from
99m
TC.
Press and release
Radionuclide Selection
button [21] until desired
radionuclide is lit
Radionuclide Selection Indicator [ 3] is lit
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Quick Start Probe with cable
Procedure for reusable cabled detector probes (Model 1017 or Model 2059).
NOTE: Model 1013 collimator is compatible with Model 1100, 1101, and 1017 probes.
NOTE: Model 1017 14mm probe connector has four pins; Model 2059 11mm probe connector has six pins.
NOTE: You hear audible click as you insert cable connector into Probe Input Connector. Connector is push/pull component - DO
NOT TWIST/TURN CABLE CONNECTOR, damage to connectors and connector pins may occur.
3. DYNAMIC PITCH MODE (DEFAULT)
Radioactive isotopes are traced in Dynamic Pitch Mode from injection site to other areas of concentration.
When sound is off, Mute symbol [17] flashes; when
sound is on, Mute symbol [17] is constant
Count Range
Default Background Count
100
2
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Background Count in Dynamic Pitch Mode
Background Count [8] is used as minimum value for selected range. Background Count [8] displays default value for
Dynamic Pitch range; Ratio Readout [9] is off; and Target Count [7] displays count rates as probe moves over body
tissue.
BACKGROUND COUNT
How to acquire Background Count
Place probe tip on target area.
Press and release Background Count Button [14]; a single Start Beep will sound; hold probe steady 2 to 6
seconds until Count Bar [6] is full and a double Stop Beep sounds.
Console display
Background Count Symbol [13] flashes.
Background Count Readout [8] displays dashes.
Count Bar [6] fills from bottom to top as data is collected.
Target Count Readout [7] is blank and is stopped temporarily.
Background Count Value
Background Count Readout data [8] will remain until a new Background Count is performed, Count Range [18] is
changed, Dynamic/Binary Pitch button is pressed, or system is switched off.
Set Dynamic Pitch range
Physician generally sets Dynamic Pitch Range [18] based on maximum count rates expected in order to achieve
highest result for a given Dynamic Pitch Range. Default Background Count values are displayed in table below.
Background Count is greater than or equal to 80% of
maximum value of selected Count Range
Example: 800 is displayed for 1,000 Count Range
Background Count is less than or equal to 2% of
maximum value of selected Count Range
Example: 20 is displayed for 1,000 Count Range
Background Count button [14] is pressed during
background count
Ratio is not calculated during Target Count. A Start
Beep sounds and Background Count restarts
Background Count button 14] is pressed while
Background Count value is displayed
A new Background Count starts
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Operational Notes
Events that may occur during product use:
Scanning to Locate Concentrated Areas of Radioactivity
Physician scans target areas to locate radioactivity after setting Background Count and Dynamic Pitch Ranges.
System status
Target Count Readout [7] displays Count Rate value; Count Bar [6] is on and displays Count Rate activity. Audible
signal may be heard, depending on Count Rate, Dynamic Pitch Range selection, and Volume settings.
Scanning procedure
Physician slowly scans by moving probe over target tissue at a rate of 1-2 centimeters per second (cm/s). Sound rises
in pitch as Count Rate increases from Background Count Value to Dynamic Pitch maximum value.
SCAN OVER TARGET AREA
NOTE: Count is too high to be displayed when Count Bar [6] fills to top and flashes with varying audio. To correct,
press and release Dynamic Pitch Range Button [18] for next higher Dynamic Count Range, and perform a new
Background Count if necessary. Optionally, press, hold and then release any Dynamic Range button (18) to activate
“Autorange Function”, see autorange instructions below.
Acquiring Target Count in Dynamic Pitch Mode
Acquire Target Count to identify intensity of gamma radiation in surrounding area.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
TARGET COUNT
Acquire Target Count
Hold probe stationary over target area to achieve highest Target Count Readout value [7], highest Count Bar
level, and highest sound.
Press and release Target Count Button [11]; keep probe steady over target area for 1 to 6 seconds until Count
Bar [6] is full and a double Stop Beep sounds.
Collect Target Count
Target Count Symbol [10] flashes green.
Target Count Readout [7] displays dashes.
Count Bar [6] fills from bottom to top as data is collected.
Target Count Value
Target Count Readout data [7] is displayed for 5 seconds; Target Count Symbol (10) flashes green.
Count Bar [6] is off.
After 5 seconds, double Stop Beep sounds and system returns to Dynamic Pitch Mode, displaying last
calculated Background Count [8] and current Count Rate [7].
Acquiring Target Count Ratio in Dynamic Pitch Mode
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Acquire a Target Count Ratio
Hold probe stationary over target area. Press and release Background Count Button [14]. Background Count
must be greater than default value (2%) of Count Range selected in order to activate Ratio Calculation
function.
Hold probe stationary over target area. Press and release Target Count Button [11] until a beep sounds; hold
probe steady over target area for 1 to 6 seconds until Count Bar [6] is full and a double Stop Beep sounds.
Collect a Target Count
Target Count Symbol [10] flashes amber.
Target Count Readout [7] displays dashes.
Count Bar [6] fills from bottom to top as data is collected.
Target Count Value
Target Count Readout data [7] and Ratio Readout [9] are displayed for 5 seconds; Target Count Symbol [10]
flashes amber.
Amber Ratio Symbol [12] displayed below Target Count Symbol [10].
Count Bar [6] off.
After 5 seconds, a double Stop Beep sounds and system returns to Dynamic Pitch Mode displaying last
calculated Background Count [8] and current Target Count [7] data.
Acquiring Ten Second Count in Dynamic Pitch Mode
TEN SECOND COUNT
Acquire a Ten Second Count
Hold probe stationary over target area.
Press and hold Target Count Button [11] until beep sounds; then release button.
Hold probe steady for 10 seconds over target area until Count Bar [6] is full and double Stop Beep sounds.
Collect Ten Second Target Count
Target Count Symbol [10] flashes green.
Target Count Readout [7] displays dashes.
Count Bar [6] fills from bottom to top as data is collected.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Ten Second Target Count Value
Note: Value displayed is not counts per second. Value is total counts obtained in 10 seconds.
10 second Target Count [7] displayed for 5 seconds; Target Count Symbol [10] flashes amber.
“10” is displayed below amber Target Count Readout, and message “secnd” displayed in green.
Count Bar [6] off.
After 5 seconds, double Stop Beep sounds and system returns to Dynamic Pitch mode, displaying last
calculated Background Count [8] and current Target Count Readout data [7].
How to Use Autorange
Console has 4 preset ranges: 100; 1000; 10000; and 50000 counts per second. Physician can define a different range
with Autorange function.
Hold probe stationary over target area to achieve highest Target Count Readout data [7] and highest sound.
Press and hold one of four Dynamic Pitch Range Buttons [18] until beep sounds, release button. Hold probe
steady over target area until Count Bar [6] is full and double Stop Beep sounds.
NOTE: Press and release any Dynamic Pitch Range Button [18] to return to default settings for desired range.
NOTE: If Target Count Value [7] is greater than maximum value of desired Dynamic Pitch Range [18], then
Count Bar [6] is full and flashes with varying beep.
Console display
Target Count Readout data [7] is displayed.
Background Count Data [8] is blank.
Count Bar [6] fills from bottom to top as data is collected; double Stop Beep sounds when completed.
NOTE: Autorange feature sets maximum data point of user defined range to 125% of Target Count [7] acquired
during Autorange process.
Background Count [8] is set to either 2 counts per second or 2% of full scale, whichever is greater.
Selected Dynamic Pitch Range light [18] flashes.
Sound is off, Mute Symbol flashes
Sound is on, Mute Symbol is steady
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Background Count in Binary Pitch Mode
Background Count establishes baseline data for radioactivity level of normal tissue. System compares background
data to radioactivity level of Target Tissue when a Target Count is performed.
System status before background count
Background Count Readout [8] displays number “7” as a default value; Ratio Readout [9] is off; and Target Count
Readout data [7] updates count rates every one-half second as probe moves over tissue.
How to acquire background count
Place probe tip on normal tissue (e.g., normal adjacent tissue, etc.)
Press and release Background Count Button [14]; single beep sounds. Hold probe steady for 6 seconds; beep
stops.
Console display
Background Count Symbol [13] flashes
Background Count Readout [8] displays dashes
Count Rate [7] is temporarily blank
Count Bar [6] fills from bottom to top as data is collected for 6 seconds.
Background count display
After 6 seconds, Background Count Data [8] is constant until a new Background Count is taken; Binary Pitch
Overflow Symbols “/////”on
Background Count Readout (7) and beep
sounds
/////
Background Count Button (14) is
pressed while a count is in progress
A Start Beep sounds; starts new
Background Count calculation
Background Count Button (14) is
pressed after Background Count Readout
data (7) is displayed
Starts new Background Count
calculation
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Operational Note
Events that may occur during product use:
Scanning to Establish Boundaries of Target Tissue in Binary Pitch Mode
Scan target tissue to locate area of localized radioactivity after Background Count Calculation is completed.
Scanning procedure
Scan for radioactivity by moving probe slowly over tissue at a rate of 1 or 2 centimeters per second (cm/s).
When radioactivity exceeds Background Count Data by a statistically significant amount, beep sounds to indicate
target tissue with localized radioactivity.
Mark perimeter of Target Tissue.
Count display
Count Rate is displayed in Target Count Readout [7]. No Target Count or Ratio is displayed during scanning
procedure.
Acquiring Target Count (6-Second Option)
System status before Target Count
Background Count Readout [8] displays Background Count Data.
Ratio Readout [9] is off.
Target Count Readout [8] displays count rates as probe is moved over tissue.
How to Acquire Target Count
Hold probe stationary over Target Tissue.
Press and hold Target Count Button [11] until Start Beep sounds. Release button.
Hold probe steady 6 seconds until Stop Beep sounds.
Console Display
Target Count Symbol [10] changes from green to amber and flashes.
Target Count Readout [7] displays dashes.
Count Bar [6] fills from bottom to top as data is collected for 6 seconds.
Target Count and Ratio Display
Target Count Readout data [7] and Ratio Count Data [9] are displayed for 5 seconds. Target Count Symbol
Target Count Button [11] is activated
(press and hold) while a Target Count is
calculated
Start Beep sounds and starts new Target
Count
Target Count [7] is too high
Overflow symbol “/////” is displayed in
Target Count Readout (7) and beep
sounds
/////
Target Count button [11] is pressed twice
while Target Count Readout data is
displayed
Starts new Target Count
Calculated Ratio Readout data is greater
than 99.9
Overflow symbol “///”appears in Ratio
Readout (9)
///
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Ratio Readout [9] is displayed. Ratio Symbol [12] flashes.
After 5 seconds, system returns to Binary Pitch Mode displaying last calculated Background Count data [8]
and current Count Rate data [7].
TARGET COUNT; 6-SECOND OPTION
Operation Note
Events that may occur during product use:
Performing a Target Check (2-Second Option)
Perform a 2-second Target Check to obtain a quick reading of radioactivity level of target tissue.
System status before Target Check
Background Count Readout [8] displays Background Count Data.
Ratio Readout [9] is off.
Target Count [7] displays count rate as probe is moved over tissue.
How to perform Target Check
Hold probe stationary over target tissue.
Press and release Target Count Button [11]; Start Beep sounds.
Hold probe steady for 2 seconds until Stop Beep sounds.
Overflow Symbol “/////” is displayed in
Target Count Readout [7] and beep
sounds
/////
Target Count Button [11] is pressed
while Target Count is displayed
Target Count Readout [7] changes to
Binary Pitch Mode and displays Target
Count data
Step
System shutdown and reuse
1
Press and release Standby/On button [1]
2
Disconnect power cord
3
Clean console and power cord; wrap power cord around posts on rear panel of console
4
Separate and clean external collimator and probe
5
Sterilize external collimator and probe if no sterile surgical drape is used
ITEM
DESCRIPTION
Count Rate
A continuous rate of gamma radiation measured in counts per second and updated every one-half
second. Count Rate is displayed on same line of LED screen as Target Count data and Target
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Count Bar [6] fills from bottom to top as data is collected for 2 seconds.
Target Check Display
Target Check data is displayed in Target Count Readout [7] for 5 seconds; Target Count Symbol [10] flashes
green.
After 5 seconds, system returns to Binary Pitch mode displaying last calculated Background Count data [8]
In Dynamic Pitch Mode: a baseline value in counts per second stored in console and used as
threshold to activate sound
In Binary Pitch Mode: baseline value in counts per second stored in console for comparison to
Target Count determines if difference in radioactivity between Background Tissue and Target
Tissue is statistically significant.
Compton Scattering
Radioactive noise at an energy level lower than photo peak of radioactive material.
Ratio Readout
A value indicating how likely it is that Target Tissue is identified (Target Count divided by
Background Count).
Dynamic Pitch
Default mode of operation: baseline value measured in counts per second that is stored in console,
and used as threshold at which sound is activated.
Binary Pitch
Optional mode of operation: baseline value measured in counts per second that is stored in console
for comparison to Target Count determines if difference in radioactivity between Background
Tissue and Target Tissue is statistically significant.
Scan/Scanning
Moving probe across Target Area to locate highest radiation reading.
Target Area
Area of interest selected by physician during a procedure
Target Check
Binary Pitch Mode Only: quick check of level of radioactivity measured in counts per second
detected by a probe held stationary for 2 seconds over target tissue; more accurate than Count
Rate. Target Check function does not display a calculated Ratio Readout.
Target Count
Number indicating level of radioactivity detected by probe when held stationary for 6 seconds
over Target Tissue; more accurate than Target Check. Target Count activates and displays a
calculated Ratio Readout; 6 seconds in Binary Pitch mode; 1 to 6 seconds in Dynamic Pitch mode.
Caution: United States Federal Law restricts this device to sale by or on order of a physician.
+60°C
-20°C
Storage and Transit Temperature
Storage and Transit Pressure
Storage and Transit Humidity
Type CF
Warning: Follow instructions for use
CAUTION: consult accompanying documents
Standby/ON
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
CAUTION: non-sterile
WARNING: hazardous voltage or shock hazard present; follow instructions and warnings
Devicor uses recyclable materials wherever possible. There are materials in our
product that do contain risk associated with Disposal. If the need arises that
components, parts, accessories or devices at end of life need to be disposed of, we
recommend that you comply with local, state and/or international laws and
regulations for your country or area.
Radionuclide
Principal
Photo peak Energy
(keV)
Physical Half-Life
Select this Radionuclide
Indicator
Iodine-125
27-35, Te X-rays
60 days
125
I
Cobalt-57
122
270 days
57
Co
Technetium-
99m
140
6.02 hrs.
99m
Tc
Indium-111
171/245
2.83 days
111
In
Iodine-131
364
8.07 days
131
I
Flourine-18
511
110 min.
18
F
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
6. POTENTIAL APPLICATIONS
Product is used transcutaneously and intracutaneously to detect radioactive emissions from body tissues or organs
where radiopharmaceuticals are administered. Most commonly administered isotopes are listed in following table, all
are detected by this product.
NOTE: A variety of radiopharmaceuticals are available. It is responsibility of user to determine suitability and
clinical utility of chosen radiopharmaceutical or radiolabeled compound, and protocol for administering drug and
using probe intracutaneously.
External application
External gamma detection of administered isotope provides noninvasive means of gathering important physiological
and/or anatomical information. Some examples are: detection and localization of blood clot formulation using
111
In labeled platelets: evaluation of thyroid function by measuring radioactive iodine uptake; evaluation of skin or
skeletal muscle blood flow; diagnosis of testicular torsion using
99m
Tc; intracutaneous scanning for localization of
lymphatic tissue.
Intraoperative localization of lymphatic tissue
Lymphoscintigraphy is a common medical procedure employed to define lymphatic flow from a site of injection
through lymphatic tissue. Hand-held gamma probes may be useful in assisting a surgeon in localization of regional
lymph node basins draining a lesion site. This allows surgeons to identify areas within lymphatics where a biopsy of
tissue may be taken to determine histological status of lymph tissue.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Minimally invasive radioguided parathyroidectomy
A preoperative
99m
Tc -Sestamibi scan may be used on patients with primary hyperparathyroidism to localize target
parathyroid adenoma and enable limited exploration as an alternative to complete bilateral surgical exploration.
Hand-held gamma probes may be useful in assisting surgeons in intraoperative localization of target adenomas.
Gamma probes can be used to detect and localize increased uptake of
99m
Tc -99m-Sestabibi by hyperparathyroid
gland.
Evaluation of ischemic bowel
Strangulation of gut may cause ischemic bowel. Surgeon must revascularize it and determine its viability as part of
surgical protocol. Gamma probes can be used to detect intra-arterial distribution of
means of determining if gut is reperfused. Other tracers, such as
99m
Tc labeled DTPA for perfusion or
99m
Tc labeled red blood cells as a
9999mTc
pyrophosphate for muscle infarction, may require investigational drug status for this application.
Perfusion of anastomosis-assessment of compromised blood flow
When a surgeon creates an anastomosis, it must be determined that each side of anastomosis has adequate perfusion;
otherwise, anastomosis may fail, and leakage may occur. A high degree of morbidity is associated with this failure.
Gamma probes provide opportunity to assess perfusion before and after creating anastomosis. Intravenous
administration of stannous pyrophosphate followed by
99m
Tc automatically labels red blood cells in vivo. Blood flow
to anastomotic ends and across anastomotic juncture can be verified with radiolabeled labeled blood cells detected by
gamma probe.
Intraoperative localization of osteoid osteomas
Osteoid osteoma is a small, but painful, benign bone lesion. Surgical excision is curative. Modern radiographic
techniques externally image lesion with
99m
Tc labeled pyrophosphate. However, because of their size (rarely greater
than 1 centimeter) and location within cortical bone, it may be difficult for surgeon to localize lesion intraoperatively.
A gamma probe may be useful in localizing a lesion site intraoperatively. Additionally, checking high concentration
of radioactive isotope in removed bone fragments provides evidence that nidus is being excised.
7. Cleaning & Disinfection
Follow precautions established in your facility when handling any medical device that has been in contact with body
fluids, tissues, or blood (intraoperative). All medical devices used intraoperatively must be cleaned, decontaminated
or sterilized before reuse.
labeled
WARNING: Do not clean console or accessories when energized. Disconnect power cord from console
and from power outlet before cleaning. Do not sterilize console or immerse it in fluids. Attempting to do so will
cause permanent damage. Damp wipe only.
CAUTION: Following general warnings apply to sterilization of system components:
Do not sterilize console
Use only approved sterilization procedures described with each probe or accessory.
Do not touch patient or operator with product when electrosurgical device is in use or energized.
CAUTION: Prior to sterilization, probe and collimator should be inspected to ensure:
Cleanliness
Power cable is free of cracks or cuts
Connectors are completely dry
Cleaning and Disinfection of probes, cables and collimators according to EN ISO 17664:2004
STERRAD® SYSTEM Reprocessing of probes, cables and collimators according to EN ISO
17664:2004
Ethylene Oxide (EO) Reprocessing of probes, cables and collimators according to EN ISO
17664:2004
Autoclave Reprocessing of collimators according to EN ISO 17664:2004
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
External collimator is removed from probe.
Approved Cleansers/Sterilizers
The console is compatible with following cleaning and disinfection agents/processes:
Control III (Maril Products, Inc.) – probes cables, collimators & connectors
Metrizyme (Metrex Research Corporation) – probes cables, collimators & connectors
Mild Soap and Water Solution – all products
Tor-II (Huntington Laboratories) – all products
Ammonia and 97% water – all products
Clorox and 90 to 95% water – all products
MediClean Forte – all products
MediZym – all products
Isopropyl Alcohol 70% (rubbing alcohol) – all products
The accessories are compatible with the cleansers listed above and the sterilizers listed below. Refer to individual
Cleaning and Sterilization Instruction for Use Documents on Manual CD included with product for detailed
instructions. See list of documents below:
NOTE: cleaning agents not listed above are sole responsibility of user to adequately assess and validate.
CAUTION: When using radioactive materials, use safe and proper handling techniques. See your
institution’s radiation safety officer about nuclear regulation commission and other requirements.
Radioactive decontamination procedures
An increase in counts without a known radioactive source may indicate radioactive contamination of environment,
probe or accessories. If high count is detected in absence of a radioactive source, then probe and collimator should be
cleaned with a radioactive decontaminant solution (e.g., Radiacwash®).
Follow standard nuclear medicine decontamination techniques. Wash probe with a decontaminant solution (e.g.
Radiacwash®) using a soft gauze pad. Pay particular attention to cleaning recesses, crevices and mating surfaces
with a soft brush. Do not scratch or abrade surfaces. Treat spent cleaning solution as radioactive waste and do not
allow it to contaminate other surfaces. Dispose of pads and cleaning solution in approved containers.
Devicor Medical Products, Inc.
300 E-Business Way, Fifth Floor
Cincinnati, OH 45241 USA
Method: Cleaning & Disinfection
Symbol:
Model 2300
WARNING:
WARNING: disconnect control unit from power source before cleaning to avoid
electrical shock.
Limitations on
reprocessing:
Repeated processing has little effect on instrument. End of life is normally determined by
abrasion, wear and damage. DAMP WIPE ONLY.
INSTRUCTIONS:
Point of use:
Remove excess soil and surface contamination with disposable cloth/paper wipe.
Containment &
Transportation:
No particular requirements. Recommend reprocessing instrument soon after surgical use.
Preparation for
cleaning:
WARNING: disconnect control unit from power source before cleaning to avoid
electrical shock.
Cleaning - Automated:
Do not use automated cleaning. Clean by hand; cleaning instructions below.
Cleaning: Manual
Equipment: mild detergent, clean gauze pad or lint free cloth, and clean soft brush.
Method:
1. Dampen cloth with mild detergent and wipe excess soil from surface
2. Clean air flow vents with dry brush
3. Visually inspect for cleanliness
4. Repeat steps 1 to 3 until visually clean.
5. Allow to dry in room air
Disinfection:
No requirement
Drying:
Air dry at room temperature
Maintenance:
Do not use damaged instruments
Inspection & Function
Testing:
All instruments: Visually inspect for damage or wear. Where instruments form part of a
larger assembly, check assembly with mating components.
Packaging:
No requirement
Sterilization:
Console does not require sterilization
Storage:
No requirement
Additional Information:
Remove debris near power button and probe input connector. Do not allow moisture to
enter through display or other openings.
Manufacturer Contact:
See troubleshooting section for telephone and address of local representative or telephone
1-877-926-2666.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Reprocessing of Console according to EN ISO 17664:2004
Devices(s): Reusable control units comprising fixed assemblies (no moving parts); sold nonsterile.
NOTE: Instructions provided above are validated by medical device manufacturer as being capable of preparing a
medical device for re-use. It remains responsibility of reprocessor to ensure that reprocessing is actually performed using
equipment, materials, and personnel in processing facility to achieve desired result. This requires validation and routine
monitoring of processes. Likewise any deviation by processor from instructions provided should be properly evaluated for
effectiveness and potential adverse consequences.
Devicor Medical Products, Inc.
300 E-Business Way, Fifth Floor
Cincinnati, OH 45241-2378 USA
Method: Cleaning & Disinfection
Symbol:
Model 2009
WARNING:
WARNING: disconnect power cord from power source before cleaning to avoid
electrical shock.
Limitations on
reprocessing:
Repeated processing has little effect on cable. End of life is normally determined by
abrasion, wear and damage due to use.
INSTRUCTIONS:
Point of use:
Remove excess soil and surface contamination with disposable cloth/paper wipe.
Containment &
Transportation:
No particular requirements. Recommend reprocessing instrument soon after surgical use.
Preparation for
cleaning:
WARNING: disconnect power cord from power source before cleaning to avoid
electrical shock
Cleaning - Automated:
Do not use automated cleaning. Clean by hand; cleaning instructions below.
Cleaning: Manual
Equipment: mild detergent and lint free cloth.
Method:
1. Dampen cloth with mild detergent and wipe excess soil from surface
2. Visually inspect for cleanliness
3. Repeat steps 1 to 3 until visually clean.
4. Allow to dry in room air
Disinfection:
No requirement
Drying:
Air dry at room temperature
Maintenance:
Do not use worn, cracked or damaged cable
Inspection & Function
Testing:
All instruments: Visually inspect for damage or wear. Where cable forms part of a larger
assembly, check assembly with mating components.
Packaging:
No requirement
Sterilization:
Power cord does not require sterilization
Storage:
No requirement
Additional Information:
Periodically perform safety test with equipment system to assure continued integrity of
power cord.
Manufacturer Contact:
See troubleshooting section for telephone and address of local representative or telephone
1-877-926-2666.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Reprocessing of Power Cord according to EN ISO 17664:2004
Devices(s): Reusable power cords comprising fixed assemblies (no moving parts); sold nonsterile.
NOTE: Instructions provided above are validated by medical device manufacturer as being capable of preparing a
medical device for re-use. It remains responsibility of reprocessor to ensure that reprocessing is actually performed using
equipment, materials, and personnel in processing facility to achieve desired result. This requires validation and routine
monitoring of processes. Likewise any deviation by processor from instructions provided should be properly evaluated for
effectiveness and potential adverse consequences.
Replace new 1.6 AMP/250V slow blow, low breaking capacity, T1.6AL 250V fuses.
Replacing fuse with incorrect rating will compromise safe operation, may cause permanent
damage, and void warranty.
3.
Reinstall fuse holder.
Step
Procedure
Result
1
Press and hold Dynamic/Binary Pitch
Mode Selection Button [4] press and
release Mute Button [16] to enter
Diagnostic Mode
Background Count Readout [8]
displays message “diag”.
diag
2
Press and hold Dynamic/Binary Pitch
Mode Selection Button [4]. Press and
release Dynamic Pitch Range 100
Button to activate visual indicator test
mode (vitm).
LED components on top half of LED
screen are lit.
Note: LED components on bottom half
of LED screen are off.
Vitm
3
Press and release Target Count Button
[11].
Target Count Readout color changes
from green to amber.
4
Press and release Background Count
Button [14].
LED components on bottom half of
LED screen are lit. Background Count
Readout displays message “vitm”.
Note: LED components on top half of
LED screen are off.
Vitm
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
8. MAINTENANCE
Product must be serviced by competent service technicians or engineers. Preventative maintenance is limited to
external cleaning of console, fuse replacement and functional diagnostics. Probes, collimators and cables are sealed or
do not contain serviceable components and cannot be repaired.
CAUTION: Perform safety testing of current leakage and ground continuity tests with power cable
attached as part of routine maintenance of product. This will ensure that power cord continues to be suitable
and safe for use.
User Calibration and Repair
Do not open console. Console is set to factory specifications. Console design is optimized for digital operation and
does not contain any analog adjustments.
Fuse Maintenance
Fuses can be accessed and replaced in AC Power Inlet Connector [25] located at rear of console. Table below
describes how to replace fuses (2 each).
CAUTION: disconnect power cord from console before checking fuses.
NOTE: Both fuses are required for proper operation.
Diagnostic Mode: Press and hold
Dynamic/Binary Pitch Mode Selection
Button [4], press and release
Background Count Button [14].
A double Stop Beep sounds and
Background Count Readout displays
“diag”.
diag
6
Exit Diagnostic Mode - press and hold
Dynamic/Binary Pitch Mode Selection
Button [4], press and release Mute
Button [16].
Exits Diagnostic Mode.
Step
Procedure
Result
1
Press and hold down Binary
Pitch/Dynamic Pitch mode selection
button and press Mute button - release all buttons at once
Background count displays “diag”.
diag
2
Enter Input Controls Test Mode
(ictm) - Press and hold down Binary
Pitch/Dynamic Pitch mode selection
button and press Dynamic Pitch range
1000 button - - release all buttons at
once
Background count displays “ictm”.
ictm
3
Press and release buttons in order
listed below:
Continuous tone sounds and message
is displayed in Target Count Readout
[7]:
Radionuclide
Bu0
Target count
Bu1
Background count
Bu2
Mute
Bu3
Binary pitch/dynamic pitch
mode
Bu4
Count range 100
Bu5
Count range 1,000
Bu6
Count range 10,000
Bu7
Count range 50,000
Bu8
4
To exit ITCM Mode, press and hold
Binary Pitch/Dynamic Pitch selection
button, and while holding it down,
press and release Background Count
button
A double chime tone is heard and
Background Count display displays
“diag”.
diag
5
Exit Base Diagnostic Mode - press
Exit Diagnostic Mode
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
and hold down Binary Pitch/Dynamic
Pitch mode selection button and press
Mute button - release all buttons at
same time
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
System Accuracy Check
Following procedure is used to confirm performance of system components is stable and consistent.
NOTE: Individuals from Nuclear Medicine department familiar with radioactive emissions and measuring equipment
should perform System Accuracy Check below. Ensure that source strength, distance from probe to source, and stray
radiation from other sources do not adversely affect measurements taken. Ensure distance between probe and
radiation source does not change during System Accuracy Check.
Product design includes solid-state sensor and digital electronics technology that does not require periodic
adjustments to compensate for gain “drift” commonly associated with analog photomultiplier electron tube designs.
Use and maintain product as described in this manual. Product is not expected to exhibit any performance drift over
prescribed lifecycle.
Before performing quality checks, make sure probe with BLUETOOTH® wireless technology is clean and free from
sources of radioactive contamination. All other sources of radiation emission must be removed from proximity of
probe during procedure. Shielding materials should be positioned to minimize effects of scatter and fluorescence
peaks from radioactive source. Use a 57Co radioactive source with known strength between 5 and 25 micro Curies
(185 to 925 kBq) during these procedures. Results will differ if you use another radionuclide, source strength, or
source location.
NOTE: Readings will differ between probe types. See battery housing of Wireless Probes for “” or “
” marking.
1) Wireless Probe with “” marking, or “” with software version 5.02 or earlier Photo Peak
Efficiency
Only conduct this test with BLUETOOTH® wireless technology enabled probes.
1. Turn on and link a probe to console.
2. Set to Dynamic Pitch mode with
99m
Tc radionuclide selected.
3. Place 57Co radioactive source 20mm in front of probe (or use P-405 Check Source Fixture). Place probe and
source in air above a table or other surface to minimize effects of scattered radiation on measurement.
4. On console, press and hold Target Count Button to perform a 10 second count. Make sure probe does not
move during this process. Record this value.
5. Press and hold Radionuclide Selection button on back of console to select Open Window (v5.01 and later)*.
6. On console, press and hold Target Count Button to perform a 10 second count. Make sure probe does not
move during this process. Record this value.
7. Divide
99m
Tc count from step 4 by open window count from step 6. Result should be greater than 40%.
8. Count-rate ratio determined by this procedure should be stable and consistent over time within expected +/-
10% statistical variation of radioactive emissions during recommended counting intervals.
*NOTE: v4.01 or earlier software does not have Open Window feature, select
125
I to perform this procedure.
2) Cabled Probe, or Wireless Probe with“” and software version 6.01 or later Photo Peak Efficiency
1. Set unit to Dynamic Pitch mode and press Radionuclide selection button on back of unit to select 57Co
radionuclide.
2. Place 57Co radioactive source 20mm in front of probe (or use P-405 Check Source Fixture). Place probe and
source in air above a table or other surface to minimize effects of scattered radiation on measurement.
3. Press and hold Target Count Button to perform a 10 second count. Record this value. Make sure probe does
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
4. Press Radionuclide Selection button on back of unit to select an open energy window (select
125
I Radionuclide
for units with v2.01 or earlier software or press and hold Radionuclide button for an open energy window in
units with v2.02 or later software.)
5. Press and hold Target Count Button to perform a 10 second count. Record this value. Divide 57Co 10-second
count by open energy window 10-second count. Results should be greater than 50%.
6. Count-rate ratio determined by this procedure should be stable and consistent over time within expected
+10% statistical variations of radioactive emissions during recommended counting intervals.
If result indicates variation from specified amount, and indicates performance has changed or is not stable, check for
proper setup with desired Radionuclide selected, and that all external factors (source, strength, source distance, stray
radiation, etc.) have been determined and controlled. Contact Devicor Medical Products, Inc. for technical assistance.
Performance Check
Perform periodic performance checks to assure proper performance of product. No calibration or adjustments are
needed. Regardless of probe type or radioisotope in use, this performance check is a simplified procedure that will
check proper performance of system with either probe type.
Performance check procedure
This performance check should be performed before each use.
1. Place probe near source of radioactivity, i.e., injection site on patient. Verify that registered counts are greater
than zero.
2. Position probe several feet away from source of radioactivity. Verify that registered count level decreases from
source count level.
If performance check does not meet conditions of Steps #1 and #2 above, consider following:
If probe fails to detect measureable levels of gamma emissions when positioned over source of radioactivity,
check that power is on and that correct radionuclide is selected. For low counts, run system diagnostic checks to
test all visual indicators are functioning properly. Contact Devicor Medical Products, Inc. for technical assistance
if problem continues.
If console displays error codes “error 2” through “error 6” when powered on, or anytime during operation,
cycle power to console. Contact Devicor Medical Products, Inc. if error codes continue.
If console indicates high level of gamma emissions when probe is pointed away from radioactive source, and no
other source of radiation is known, move to another room and repeat low count performance check.
o If counts go down, there must be another source of radioactivity in room or patient source is too high.
o If counts do not go down, probe may be contaminated and should be cleaned with a radioactive
decontaminant solution (e.g., Radiacwash®), or probe has internal mechanical damage.
Troubleshooting
Use this table to identify and correct problems. Additional information is provided in service manual.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Questions
Call Devicor Medical Products, Inc. at 1-877-926-2666.
Service Policy
New Product Warranty Service
Call 1-877-926-2666 for authorization to return products to Devicor. Provide model, serial or lot numbers of
defective product, technical description of defect or malfunction, no-charge purchase order number, and your
shipping and billing address. Also obtain return merchandise authorization (RMA) number from Devicor.
Out-of-Warranty Service
Call 1-877-926-2666 for authorization to return product to Devicor. Provide model, serial or lot number of
defective product, technical description of defect or malfunction, billable purchase order number to cover
Devicor’s estimate of repair cost, and shipping and billing address for Buyer. Also obtain return merchandise
authorization (RMA) number from Devicor.
Return product in original packing and Label packaging with RMA number. Shipment to Devicor is at Buyer’s
expense. Repaired or replacement equipment is shipped C.I.P. from Devicor’s plant. Reported problems or defects
not verified by Devicor are subject to additional charge(s).
Repair of product is warranted for 90 days from date of shipment to Buyer. Limited warranty applies only to repaired
defective product and does not apply to product when no defect was found.
Devicor uses recyclable products and materials when possible. Follow all local, state and/or international laws and
regulations for proper disposal of components, parts or accessories. Contact Devicor at 1-877-926-2666 if you
cannot find a convenient means of disposal.
New Product Warranty
New products manufactured by Devicor are warranted against defects in workmanship and material for period of one
year (period) from date of shipment by Devicor to Buyer, subject to limitations hereinafter set forth. Should any
defects be found and reported during period, Devicor, at its option, will repair or replace such defective product
provided Buyer ships defective product to Devicor, transportation charges prepaid, with notice of defect and
certification that product was properly installed, maintained, and operated within limits of rated and normal usage.
Repaired or replacement product is shipped C.I.P. from Devicor’s plant to Buyer. Terms of product warranty do not
extend to product or part which, under normal usage, has expected useful life of less than one year.
Warranty shall not apply to product where installation or servicing of product is improper, or where product is
operated outside rated load capacity, or included in accident, tampering, alteration, or abuse. DEVICOR’S
LIABILITY UNDER THIS WARRANTY OR ANY OTHER WARRANTY WHETHER EXPRESS OR IMPLIED
IN LAW OR FACT IS LIMITED TO REPAIR OR REPLACEMENT OF DEFECTIVE MATERIAL AND
WORKMANSHIP, AND IN NO EVENT SHALL COMPANY BE LIABLE FOR CONSEQUENTIAL OR
INDIRECT DAMAGES.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
THIS WARRANTY CONTAINS THE ENTIRE OBLIGATION OF DEVICOR AND NO OTHER WARRANTIES
INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A
PARTICULAR PURPOSE OR OTHER WARRANTIES EXPRESSED, IMPLIED, OR STATUTORY ARE
GIVEN.
9. SYSTEM SPECIFICATIONS
Model 2300 Console
NOTE: Disconnect from power source and store product in a clean environmentally controlled area.
NOTE: Use only power cords of 18 gauge wire and hospital grade plugs in compliance to one or more of these
Guidance and Manufacturer’s Declaration – Electromagnetic Emissions
The Model 2300 Gamma Detection System is intended for use in the electromagnetic environment specified below. The customer or
the user of the Model 2300 Gamma Detection System should assure that it is used in such an environment.
Emission test
Compliance
Electromagnetic environment - guidance
RF Emissions
CISPR 11
Group 2
The Model 2300 Gamma Detection System must emit electromagnetic energy in
order to perform its intended function. All emissions comply with EN 61000-4-3,
FCC and IC regulations. Nearby electronic equipment may be affected if the
Model 2300 is operated within 11.7 cm or 4.6" of equipment marked with the
following symbol:
RF emissions
CISPR 11
Class B
The Model 2300 Gamma Detection System is suitable for use in all establishments,
including domestic establishments and those directly connected to the public lowvoltage power supply network that supplies buildings used for domestic purposes.
Harmonic emissions
IEC 61000-3-2
Not applicable
Voltage
fluctuations/flicker
emissions
IEC 61000-3-3
Complies
Guidance and Manufacturer’s Declaration – Electromagnetic Immunity
The Model 2300 Gamma Detection System is intended for use in the electromagnetic environment specified below. The customer or
the user of the Model 2300 Gamma Detection System should assure that it is used in such an environment.
Immunity Test
IEC 60601 test level
Compliance level
Electromagnetic environment - guidance
Electrostatic
discharge (ESD)
61000-4-2
±6 kV contact
±8 kV air
±6 kV contact
±8 kV air
Floors should be wood, concrete or ceramic tile. If
floors are covered with synthetic material, the relative
humidity should be at least 30%.
Electrostatic fast
transient/burst
IEC 61000-4-4
±2 kV for power supply
lines
±1 kV for input/output
lines
±2 kV for power supply
lines
±1 kV for input/output
lines
Mains power quality should be that of a typical
commercial or hospital environment.
Surge
IEC 60001-4-5
±1 kV differential mode
±2 kV common mode
±1 kV differential mode
±2 kV common mode
Mains power quality should be that of a typical
commercial or hospital environment.
Voltage dips,
short interruptions
and voltage
variations on
power supply
input lines
IEC 60001-4-11
<5 % UT
(>95 % dip in UT for 0.5
cycle)
<40 % UT
(>95 % dip in UT for 5
cycles)
<70 % UT
(>30 % dip in UT for 25
cycles)
<5 % UT
(>95 % dip in UT for 5
sec)
<5 % UT
(>95 % dip in UT for 0.5
cycle)
<40 % UT
(>95 % dip in UT for 5
cycles)
<70 % UT
(>30 % dip in UT for 25
cycles)
<5 % UT
(>95 % dip in UT for 5
sec)
Mains power quality should be that of a typical
commercial or hospital environment. If the user of the
Model 2300 Gamma Detection System requires
continued operation during power mains interruptions,
it is recommended that the Model 2300 Gamma
Detection System be powered from an uninterruptible
power supply or a battery.
NOTE: UT is the AC mains voltage prior to
application of the test level.
Power frequency
(50/60 Hz)
magnetic field
3 A/m
3 A/m
Power frequency magnetic fields should be at levels
characteristic of a typical location in a typical
commercial or hospital environment.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Electromagnetic Compatibility Declaration
EMC Requirements in Accordance with EN 60601-1-2:2007
Guidance and Manufacturer’s Declaration – Electromagnetic Immunity
The Model 2300 Gamma Detection System equipment is intended for use in the electromagnetic environment specified below. The
customer or user of the Model 2300 Gamma Detection System equipment should assure that it is used in such an environment.
Immunity Test
IEC 60601-1 test
level
Compliance level
Electromagnetic environment – guidance
Portable and mobile RF communications equipment should
be used no closer to any part of the Model 2300 Gamma
Detection System equipment, including cables, than the
recommended separation distance calculated from the
equation applicable to the frequency of the transmitter.
Conducted RF
IEC 61000-4-6
3 Vrms
3 Vrms
Recommended separation distanced = 1.17 * √ P
Radiated RF
IEC 61000-4-3
3 V/m
80 MHz to 2.5 GHz
3 V/m
80 MHz to 2.5 GHz
Recommended separation distance
d = 1.17 * √ P (for 80 MHz to 800 GHz)
d = 2.33 * √ P (for 800 MHz to 2.5 GHz)
Where (P) is the maximum output power rating of the
transmitter in watts (W) according to the transmitter
manufacturer and (d) is the recommended separation distance
in meters (m).
Field strength from fixed RF transmitters, as determined by
an electromagnetic survey, a should be less than the
compliance level in each frequency range b.
Interference may occur if the Model 2300 is operated within
11.7 cm or 4.6" of equipment marked with the following
symbol:
Note 1: at 80 MHz and 800 MHz, the higher frequency range applies.
Note 2: These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from structures, objects and people.
a
Field strengths from fixed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radio, AM and FM radio broadcast
and TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to fixed transmitters, an electromagnetic site survey
should be considered. If the measured field strength in the location in which the Model 2300 Gamma Detection System equipment is used exceeds the applicable RF
compliance level above, the Model 2300 Gamma Detection System equipment should be observed to verify normal operation. If abnormal performance is observed,
additional measures may be necessary, such as reorienting or relocating the Model 2300 Gamma Detection System equipment.
b
Over the frequency range 150 KHZ to 80 MHz, field strength should be less than 3 V .
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
Recommended separation distance between portable and mobile RF communications equipment and the Model 2300
Gamma Detection System equipment
The Model 2300 Gamma Detection System equipment is intended for use in an electromagnetic environment in which radiated RF
disturbances are controlled. The customer or the user of the Model 2300 Gamma Detection System equipment can help prevent
electromagnetic interference by maintaining a minimum distance between portable and mobile communications equipment
(transmitters) and the Model 2300 Gamma Detection System equipment as recommended below, according to the maximum output
power of the communications equipment.
Rated maximum
output power of
transmitter
W
Separation distance according to frequency of transmitter
m
150KHz to 80MHz
d = 1.17 * √ P
80MHz to 800 MHz
d = 1.17 * √ P
800 MHz to 2.5 GHz
d = 2.33 * √ P
0.01
0.12m
0.12m
0.23m
0.1
0.37m
0.37m
0.74m
10
3.7m
3.7m
7.4m
100
12m
12m
23m
For transmitters rated at a maximum output power not listed above, the recommended separation distance (d) in meters (m) can be
estimated using the equation applicable to the frequency of the transmitter, where (P) is the maximum output power rating of the
transmitter in watts (W) according to the transmitter manufacturer.
NOTE 1 At 80MHz and 800 MHz, the separation distance for the higher frequency applies.
NOTE 2 These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from
structures, objects and people.
Česky
[Czech]
Devicor Medical Products, Inc. tímto prohlašuje, že tento “Wireless Probe” je ve shodě se základními požadavky a dalšími příslušnými ustanoveními směrnice 1999/5/ES.
Dansk
[Danish]
Undertegnede Devicor Medical Products, Inc. erklærer herved, at følgende udstyr “Wireless Probe” overholder de
væsentlige krav og øvrige relevante krav i direktiv 1999/5/EF.
Deutsch
[German]
Hiermit erklärt Devicor Medical Products, Inc., dass sich das Gerät “Wireless Probe” in Übereinstimmung mit den
grundlegenden Anforderungen und den übrigen einschlägigen Bestimmungen der Richtlinie 1999/5/EG befindet.
Eesti
[Estonian]
Käesolevaga kinnitab Devicor Medical Products, Inc. seadme “Wireless Probe” vastavust direktiivi 1999/5/EÜ
põhinõuetele ja nimetatud direktiivist tulenevatele teistele asjakohastele sätetele.
Español
[Spanish]
Por medio de la presente Devicor Medical Products, Inc. declara que el “Wireless Probe” cumple con los
requisitos esenciales y cualesquiera otras disposiciones aplicables o exigibles de la Directiva 1999/5/CE.
Ελληνική
[Greek]
ΜΕ ΤΗΝ ΠΑΡΟΥΣΑ Devicor Medical Products, Inc. ΔΗΛΩΝΕΙ ΟΤΙ “Wireless Probe” ΣΥΜΜΟΡΦΩΝΕΤΑΙ
ΠΡΟΣ ΤΙΣ ΟΥΣΙΩΔΕΙΣ ΑΠΑΙΤΗΣΕΙΣ ΚΑΙ ΤΙΣ ΛΟΙΠΕΣ ΣΧΕΤΙΚΕΣ ΔΙΑΤΑΞΕΙΣ ΤΗΣ ΟΔΗΓΙΑΣ
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
EMC Requirements in Accordance with EN 60601-1-2:2007
Table 206
Declaration of Conformance:
Hereby, Devicor Medical Products, Inc. declares that this “Wireless Probe” is in compliance with the essential requirements and other
relevant provisions of Directive 1999/5/EC.
Par la présente Devicor Medical Products, Inc. déclare que l'appareil “Wireless Probe” est conforme aux
exigences essentielles et aux autres dispositions pertinentes de la directive 1999/5/CE.
Italiano
[Italian]
Con la presente Devicor Medical Products, Inc. dichiara che questo “Wireless Probe” è conforme ai requisiti
essenziali ed alle altre disposizioni pertinenti stabilite dalla direttiva 1999/5/CE.
Latviski
[Latvian]
Ar šo Devicor Medical Products, Inc. deklarē, ka “Wireless Probe” atbilst Direktīvas 1999/5/EK būtiskajām
prasībām un citiem ar to saistītajiem noteikumiem.
Lietuvių
[Lithuanian]
Šiuo Devicor Medical Products, Inc. deklaruoja, kad šis “Wireless Probe” atitinka esminius reikalavimus ir kitas
1999/5/EB Direktyvos nuostatas.
Nederlands
[Dutch]
Hierbij verklaart Devicor Medical Products, Inc. dat het toestel “Wireless Probe” in overeenstemming is met de
essentiële eisen en de andere relevante bepalingen van richtlijn 1999/5/EG.
Malti
[Maltese]
Hawnhekk, Devicor Medical Products, Inc., jiddikjara li dan “Wireless Probe” jikkonforma mal-ħtiġijiet essenzjali u ma provvedimenti oħrajn relevanti li hemm fid-Dirrettiva 1999/5/EC.
Magyar
[Hungarian]
Alulírott, Devicor Medical Products, Inc. nyilatkozom, hogy a “Wireless Probe” megfelel a vonatkozó alapvetõ
követelményeknek és az 1999/5/EC irányelv egyéb elõírásainak.
Polski
[Polish]
Niniejszym Devicor Medical Products, Inc. oświadcza, że “Wireless Probe” jest zgodny z zasadniczymi wymogami
oraz pozostałymi stosownymi postanowieniami Dyrektywy 1999/5/EC.
Português
[Portuguese]
Devicor Medical Products, Inc. declara que este “Wireless Probe” está conforme com os requisitos
essenciais e outras disposições da Directiva 1999/5/CE.
Slovensko
[Slovenian]
Devicor Medical Products, Inc. izjavlja, da je ta “Wireless Probe” v skladu z bistvenimi zahtevami in ostalimi relevantnimi določili direktive 1999/5/ES.
Slovensky
[Slovak]
Devicor Medical Products, Inc. týmto vyhlasuje, že “Wireless Probe” spĺňa základné požiadavky a všetky príslušné
ustanovenia Smernice 1999/5/ES.
Suomi
[Finnish]
Devicor Medical Products, Inc. vakuuttaa täten että “Wireless Probe” tyyppinen laite on direktiivin 1999/5/EY
oleellisten vaatimusten ja sitä koskevien direktiivin muiden ehtojen mukainen.
Svenska
[Swedish]
Härmed intygar Devicor Medical Products, Inc. att denna “Wireless Probe” står I överensstämmelse med de
väsentliga egenskapskrav och övriga relevanta bestämmelser som framgår av direktiv 1999/5/EG.
Íslenska
[Icelandic]
Hér með lýsir Devicor Medical Products, Inc. yfir því að “Wireless Probe” er í samræmi við grunnkröfur og aðrar
kröfur, sem gerðar eru í tilskipun 1999/5/EC.
Norsk
[Norwegian]
Devicor Medical Products, Inc. erklærer herved at utstyret “Wireless Probe” er i samsvar med de grunnleggende krav
og øvrige relevante krav i direktiv 1999/5/EF.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
11. WARNINGS, CAUTIONS AND NOTES
Read this section before operating product.
DEFINITIONS:
, or WARNING: Specific information identifies events when misuse or improper use of
device may cause harm to user or patient or could result in irreparable damage to device
or property.
CAUTION: Specific information identifies when misuse of equipment may cause malfunction or
produce incorrect readings.
NOTE: General information to explain or clarify proper operation of product.
Injury
Report injuries immediately to Devicor at 1-877-926-2666 and leave product undisturbed until authorized Devicor
representative can inspect it.
ELECTRICAL:
Verify power cable is secure before each use.
Inspect cables for damage before each use. Use of damaged cables may present an electrical shock hazard.
Disconnect power cord from console to verify fuses. Only use specified rated fuses.
Disconnect power cord from source and disconnect power cord from console before cleaning product.
To avoid risk of electric shock, this equipment must only be connected to a supply mains with protective earth.
Maintain proper clearance for access to AC Power Inlet Connector for disconnection from mains power.
Risk of Fire/Explosion
DO NOT USE IN PRESENCE OF FLAMMABLE ANESTHETICS OR EXPLOSIVE GASES.
WARNINGS:
DO NOT GAMMA OR STEAM (AUTOCLAVE) STERILIZE ANY COMPONENT, PART, OR
ACCESSORY.
No modification of this equipment is allowed. Opening or tampering with product may cause damage; void
warranty.
Only properly trained personnel should operate product.
Do not sterilize or immerse in liquid as permanent damage may result.
Use of unauthorized accessories will void warranty; user assumes all liability.
Do not connect unauthorized equipment or accessories to external serial port connector during clinical use. Any person
who connects additional equipment to the signal input or signal output part configures a medical system, and is therefore
responsible for ensuring that the system complies with the systems requirements of IEC 60601-1.
CAUTIONS:
System components should not touch other electrical equipment during use.
Artwork No: AW-000639 Revision: A Artwork Status: Released Lifecycle Name: Artwork
neoprobeTM GDS Operation Manual
Do not position or use product near sources of extreme magnetism such as MRI equipment.
Operation of product in vicinity of X-ray equipment may cause incorrect counts.
Electrocautery and electrosurgical devices can interfere with system operation. Isolate system away from
electrocautery and electrosurgical devices to reduce electromagnetic interference.
Incorrect counts can occur in vicinity of persons exposed to radiation therapy.
NOTES:
Product is designed only to detect gamma radiation emissions; is not a ‘measuring device’; and does not
generate hazardous radiation.
Contact your radiation safety officer for regulatory compliance and other requirements.